Search

Your search keyword '"Careccia, A."' showing total 457 results

Search Constraints

Start Over You searched for: Author "Careccia, A." Remove constraint Author: "Careccia, A."
457 results on '"Careccia, A."'

Search Results

2. MEK-inhibitors decrease Nfix in muscular dystrophy but induce unexpected calcifications, partially rescued with Cyanidin diet

3. Traditional masonry and archaeological restoration. A case study from Salūt, Oman

4. Target and Beam-Target Spin Asymmetries in Exclusive $\pi^+$ and $\pi^-$ Electroproduction with 1.6 to 5.7 GeV Electrons

6. THE USE OF TRADITIONAL MUD-BASED MASONRY IN THE RESTORATION OF THE IRON AGE SITE OF SALŪT (OMAN). A WAY TOWARDS MUTUAL PRESERVATION

7. A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

8. Near-threshold Photoproduction of Phi Mesons from Deuterium

9. Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions

10. A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

11. Regulation of Satellite Cells Functions during Skeletal Muscle Regeneration: A Critical Step in Physiological and Pathological Conditions.

12. Lack of the transcription factor Nfix causes tachycardia in mice sinus node and rats neonatal cardiomyocytes

13. Supplementary Figure 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

14. Supplementary Figure Legends from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

15. Supplementary Figures 2 - 3 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

16. Data from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

17. Supplementary Table 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

20. Data from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

21. Supplementary Figures 2 - 3 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors

25. Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy

27. Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy

28. Tumors of the Skin

29. A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

31. Correlation analysis between churches and their artistic content in terms of damage. A damage map of Italian Cultural Heritage through four Regions after the 2016 earthquake

33. Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia

34. Charting a New Course: Overcoming the stalemate in Gaza

37. Albañilería tradicional y restauración arqueológica. El caso de Salūt, Omán

38. Evidence for a backward peak in the γd → π0d cross section near the η threshold

39. High mobility group box 1 orchestrates tissue regeneration via CXCR4

41. Exclusive ρ0 electroproduction on the proton at CLAS

42. Exploiting Live Imaging to Track Nuclei During Myoblast Differentiation and Fusion

43. Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy

44. High mobility group box 1 orchestrates tissue regeneration via CXCR4

45. MOESM11 of A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

46. Deeply virtual and exclusive electroproduction of ω-mesons

47. Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia

Catalog

Books, media, physical & digital resources